Solventum Corp. Cash Flow Conversion Efficiency

Latest as of June 2026: 0.047x

Solventum Corp. cash flow conversion efficiency. Based on the latest financial reports, Solventum Corp. (SOLV) has a cash flow conversion efficiency ratio of 0.047x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($227.00 Million) by net assets ($4.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Solventum Corp. (2021–2025)

Cash flow conversion efficiency of Solventum Corp. from 2021 to 2025. This chart illustrates how Solventum Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Solventum Corp. stock price today for real-time trading data and today's change.

Solventum Corp. Cash Flow Conversion Ratio Explained

Solventum Corp. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Solventum Corp. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Solventum Corp. ranked by their cash flow conversion efficiency. Also see SOLV market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Shenwan Hongyuan Group Co Ltd
SHE:000166
-0.034x
Evolution Gaming Group AB (publ)
F:E3G
0.069x
METSO OUTOTEC UNS.ADR 1/2
F:M6QB
0.005x
Assurant, Inc.
NYSE:AIZ
0.075x
Pershing Square Inc.
NYSE:PS
0.099x
Euronext N.V.
PA:ENX
0.018x
VERBUND AG
VI:VER
0.039x
KT&G Corp
KO:033780
0.041x

Annual Cash Flow Conversion Efficiency for Solventum Corp. (2021–2025)

The table below shows the annual cash flow conversion efficiency of Solventum Corp. from 2021 to 2025. Review SOLV FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $5.05 Billion $369.00 Million 0.073x -81.75%
2024-12-31 $2.96 Billion $1.19 Billion 0.400x +143.96%
2023-12-31 $11.67 Billion $1.92 Billion 0.164x +14.80%
2022-12-31 $11.74 Billion $1.68 Billion 0.143x -21.69%
2021-12-31 $12.06 Billion $2.20 Billion 0.183x --

About Solventum Corp.

NYSE:SOLV USA Medical Instruments & Supplies
Market Cap
$13.84 Billion
Market Cap Rank
#1683 Global
#650 in USA
Share Price
$81.33
Change (1 day)
-2.67%
52-Week Range
$62.49 - $92.44
All Time High
$92.44
About

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressing… Read more